Shots: RegenxBio to receive $7M upfront, milestones payments plus royalties on net sales. Rocket to get exclusive worldwide rights for RegenxBio’s NAV AAV9 Vector to develop and commercialize gene therapies […]readmore
Tags : Agreement
Shots: Arena to get $1.2B as total deal value, including $800M upfront plus $400M milestones and royalties on net sales of the product. United to get exclusive worldwide rights to […]readmore
Shots: Wugen to get exclusive & IPR rights for CAR-T Technologies developed by Washington University The focus of the agreement is to develop and commercialize novel CAR-T therapies to treat […]readmore
Shots: Ferring to receive the US commercialization rights for INVOcell Technology and Invo will take care of its manufacturing and supplying activities for Ferring Invo has rights to establish INVO […]readmore
Shots: Regenxbio to get $100M as total deal value plus $20M upfront ($10M paid on signing, $10M with 12 mos.) in addition to $60M milestone payment on sales Abeona to […]readmore
Shots: BioArctic to get $755M as total deal value (with upfront previously paid) and $50M milestone payments in addition to royalties on sales In 2016, AbbVie and BioArctic ($80M upfront) […]readmore
Shots: Henry to get an exclusive option to license US patent application 14/654,140 for Galectin-3 inhibitors and will acquire minority equity in G3 Pharmaceuticals The focus of the agreement is […]readmore
Shots: Ionis Pharmaceuticals will receive an upfront payment in ordinary shares $2.5M, $22.23/share representing 20% premium plus milestones payments and 20% royalties on net sales of QR-1123. ProQR to get […]readmore
Shots: Enterome to get $50M upfront plus $640M as milestones payments and future equity investment commitment from Takeda. The companies will jointly co-develop EB8018 and if approved, the product will […]readmore
Shots: Palette to receive global development rights for Nestle’s Deflux, Solesta and Barrigel and will focus on its commercialization. Nestle will continue to develop the license products for Palette The […]readmore